Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
767.000.17%
QQQ
714.250.11%
BTC/USD
77093.060.0501%
DIA
532.330.02%
GLD
423.090.06%
TLT
82.020.04%

Satellos Bioscience Inc

MSLENASDAQ
Trade with Public
Trade with Public
$10.01
-0.18-1.72%
At close: Aug 21, 5:00 PM EST
$9.97
-0.04-0.4%
After Hours: Aug 12, 4:58 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentCompareStock Report

Satellos Bioscience Analyst Price Targets

Wall Street analyst price targets and consensus rating for Satellos Bioscience (MSLE).

Price Target Range — 3 Quarters

Analyst Consensus — 4 Analysts

4Buy
Consensus RatingBuy# Analysts4Avg. Consensus PT$20Upside to Avg. PT+103.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 17, 2026HC Wainwright & Co.Arthur HeMaintainedBuy$18
Jul 9, 2026HC Wainwright & Co.Arthur HePT RaiseBuy$11→$18
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $18 Price Target

HC Wainwright & Co. analyst Arthur He reiterates Satellos Bioscience (NASDAQ:MSLE) with a Buy and maintains $18 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Satellos Bioscience, Raises Price Target to $18

HC Wainwright & Co. analyst Arthur He maintains Satellos Bioscience (NASDAQ:MSLE) with a Buy and raises the price target from $11 to $18.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $11 Price Target

HC Wainwright & Co. analyst Arthur He reiterates Satellos Bioscience (NASDAQ:MSLE) with a Buy and maintains $11 price target.
Benzinga Newsdesk

PRO
Guggenheim Initiates Coverage On Satellos Bioscience with Buy Rating, Announces Price Target of $23

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Satellos Bioscience (NASDAQ:MSLE) with a Buy rating and announces Price Target of $23.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Satellos Bioscience, Raises Price Target to $11

HC Wainwright & Co. analyst Arthur He maintains Satellos Bioscience (NASDAQ:MSLE) with a Buy and raises the price target from $1.2 to $11.
Benzinga Newsdesk

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

Top Wall Street analysts changed outlook on top names. For all analyst rating changes, see analyst ratings page. Analysts' thoughts on LGND stock.
Avi Kapoor

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved